India: Intellectual Property

The viewpoint of being able to provide cheap drugs to a population which cannot afford it has started yet another debate in the pharma sector about how drug companies should price the life saving drugs in the developing world.

In an eagerly awaited decision, India's Controller of Patents has granted a licence to generics pharmaceutical manufacturer, Natco Pharma Ltd (Natco) to manufacture Bayer's patented anticancer drug 'Naxavar'.

In Scan Biotech India & Another v Scan Biotech India , Scan Biotech India & Another (Plaintiffs), a pharmaceutical product manufacturing concern sought permanent injunction against Scan Biotech India (Defendant) for their use of the trademark "BOLRAN" and the use of the trade name "SCAN BIOTEK INDIA".

It is an absolute delight when our favourite classics hit the big screen again. One of our 2013 favourites and a masterpiece, Raanjhanaa was re-released on August 1, 2025.

India's vast and ancient cultural heritage holds deep reservoirs of Traditional Knowledge (TK)—wisdom systems, healing practices, agricultural know-how, folklore, and oral traditions passed across generations.

In a recent decision, the Delhi High Court dismissed a trademark and copyright infringement suit filed by Coromandel Indag Products India Limited (CIPL/Plaintiff)...

In recent years, global fashion houses have increasingly drawn inspiration from traditional Indian crafts and textiles.

In the rapidly evolving tech landscape, innovation and standardization are crucial for ensuring seamless interoperability between products and services.

The case of "Al-Hamd Tradenation vs Phonographic Performances Limited" centered on the issue of whether demanding exorbitant licensing fees constitutes a refusal under Section 31 of the Copyright Act, 1957, and whether such refusal would justify the grant of a compulsory license.

In today's contemporary world, a highly diverse country like India, where we can observe all kinds of people who inhabit different states. Culture forms a huge part of the identity of the people...

Observing that the plaintiffs failed to fulfil the mandatory requirements of Section 104A of the Patents Act, 1970, the Delhi High Court has held that no direction can be issued...

Biosimilar infringement disputes in India are still a comparatively new but growing field of pharmaceutical patent law. The Delhi High Court's Order dated 18 July 2025 in E.R. Squibb...